Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiac Abnormalities in Type 1 Facioscapulohumeral Muscular Dystrophy.
Labombarda F, Maurice M, Simon JP, Legallois D, Guyant-Maréchal L, Bedat-Millet AL, Merle P, Saloux E, Chapon F, Milliez P. Labombarda F, et al. Among authors: merle p. J Clin Neuromuscul Dis. 2017 Jun;18(4):199-206. doi: 10.1097/CND.0000000000000144. J Clin Neuromuscul Dis. 2017. PMID: 28538250
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX, Kang YK, Yen CJ, Finn RS, Galle PR, Llovet JM, Assenat E, Brandi G, Pracht M, Lim HY, Rau KM, Motomura K, Ohno I, Merle P, Daniele B, Shin DB, Gerken G, Borg C, Hiriart JB, Okusaka T, Morimoto M, Hsu Y, Abada PB, Kudo M; REACH-2 study investigators. Zhu AX, et al. Among authors: merle p. Lancet Oncol. 2019 Feb;20(2):282-296. doi: 10.1016/S1470-2045(18)30937-9. Epub 2019 Jan 18. Lancet Oncol. 2019. PMID: 30665869 Clinical Trial.
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
Kouton L, Boucraut J, Devaux J, Rajabally YA, Adams D, Antoine JC, Bourdain F, Brodovitch A, Camdessanché JP, Cauquil C, Ciron J, Dubard T, Echaniz-Laguna A, Grapperon AM, Juntas-Morales R, Kremer L, Kuntzer T, Labeyrie C, Lanfranco L, Léger JM, Maisonobe T, Mavroudakis N, Mecharles-Darrigol S, Merle P, Noury JB, Rouaud V, Tard C, Théaudin M, Vallat JM, Viala K, Attarian S, Delmont E. Kouton L, et al. Among authors: merle p. Clin Neurophysiol. 2020 Apr;131(4):921-927. doi: 10.1016/j.clinph.2020.01.013. Epub 2020 Feb 6. Clin Neurophysiol. 2020. PMID: 32078921
Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial.
Guiu B, Chevallier P, Assenat E, Barbier E, Merle P, Bouvier A, Dumortier J, Nguyen-Khac E, Gugenheim J, Rode A, Oberti F, Valette PJ, Yzet T, Chevallier O, Barbare JC, Latournerie M, Boulin M. Guiu B, et al. Among authors: merle p. Radiology. 2019 Jun;291(3):801-808. doi: 10.1148/radiol.2019182399. Epub 2019 Apr 30. Radiology. 2019. PMID: 31038408 Clinical Trial.
Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.
Mornex F, Girard N, Beziat C, Kubas A, Khodri M, Trepo C, Merle P. Mornex F, et al. Among authors: merle p. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1152-8. doi: 10.1016/j.ijrobp.2006.06.015. Int J Radiat Oncol Biol Phys. 2006. PMID: 17145534 Clinical Trial.
321 results